Friday, July 31, 2020

Pharmaceutical Company and Former Executives Charged With Misleading Financial Disclosures

The Securities and Exchange Commission today announced that Bausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC…

Read the Full Press Release
Have a securities law question? Call Sallah Astarita & Cox at 212-509-6544.

No comments: